Маргарита Владимировна Носова
City Clinical Hospital · 18 works · 9 citations · h-index 2
Top works
- Real world efficacy of immunotherapy in nonsmall cell lung cancer
- First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
- Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab
- Comparative analysis of induction chemotherapy followed by chemoradiotherapy and concurrent chemoradiation therapy efficacy in patients with locally advanced head and neck squamous cell cancer
- The efficacy of immune checkpoint inhibitors in patients with cancer with pseudoprogression.
- Первые результаты многоцентрового нерандомизированного проспективного исследования II фазы изучения эффективности и безопасности индукционной терапии пембролизумабом, цисплатином и 5-фторурацилом у пациентов с нерезектабельным плоскоклеточным раком ротоглотки, гортаноглотки и гортани
- Эффективность иммунотерапии у пациентов с метастатической меланомой
- Alopecia prevention during chemotherapy: from the benchmark to real clinical practice. A prospective study
- Efficacy of immunotherapy in patients with metastatic melanoma
- NGS testing for patient selection in left-sided RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy.
- Induction pembrolizumab plus cisplatin and 5-FU chemotherapy followed by chemoradiotherapy in locally advanced squamous cell cancer of oropharynx, hypopharynx or larynx: Results of multicenter prospective phase II study.
- 17eP Efficacy of cetuximab-based vs pembrolizumab-based therapy in first-line treatment of recurrent and metastatic head and neck cancer with low PD-L1 expression
- Токсичность и безопасность индукционных схем химиотерапии при местно-распространенном раке ротоглотки, гортаноглотки и гортани: нерандомизированное исследование сравнения режима DCF и иммунохимиотерапии по схеме PF – пембролизумаб
- 441P Real-world data of nivolumab efficacy for treatment of recurrent or metastatic head and neck squamous cell carcinoma
- Multicenter Prospective Phase II Study of Induction Therapy With Pembrolizumab, Cisplatin, and Fluorouracil in Patients With Locally Advanced Head and Neck Cancer
- Prognostic and predictive radiomic markers in head and neck cancer patients receiving chemoradiotherapy and systemic therapy
- Гиперселекция пациентов при назначении анти-EGFR-антител. Первые результаты отечественного исследования